Teratogenic Effects and The Role in The Etiology of Atopic Diseases of Erythrosine (FD&C Red No.3)

Erythrosine (FD&C Red No.3, di sodium salt of 2,4,5,7-tetra-iodofluorescein); is used extensively as a colour additive in foods, drugs and cosmetics. Previous studies have shown that some of the food additives, depending on their long-term and short-term use, have potential carcinogenic, toxic and teratogenic effects. In Turkey this colourant has temporary permission of use until studies are completed about it. In addition food colours may cause allergic reactioins due to food intolerance. In our study 17 pregnant rats are divided into two groups: control and erythrosine group. 7 Wistar albino rats were administered 5 ml erythrosine (2mg/ml) by gavage at 7-8-9-10-11 th days of their pregnancy. 10 rats in positive control group are given distilled water by gavage. At 20 th day of pregnancy, pregnant rats in both groups sacrificed by cervical dislocation and laparotomy applied. Each live fetus was promptly weighed and examined for congenital anomalies and the crown-rump lenght was measured. Routine fetal histologic studies and light microscopic examination of the sections stained with H&E was applied. Mast cells are examined in the fetal dermal sections stained with Toluidine Blue. In erythrosine group, there were no congenital defects, while the number of mast cells of fetal skins were increased and exocytosis was observed. This was statistically significant (U=12 p

Teratogenic Effects and The Role in The Etiology of Atopic Diseases of Erythrosine (FD&C Red No.3)

Erythrosine (FD&C Red No.3, di sodium salt of 2,4,5,7-tetra-iodofluorescein); is used extensively as a colour additive in foods, drugs and cosmetics. Previous studies have shown that some of the food additives, depending on their long-term and short-term use, have potential carcinogenic, toxic and teratogenic effects. In Turkey this colourant has temporary permission of use until studies are completed about it. In addition food colours may cause allergic reactioins due to food intolerance. In our study 17 pregnant rats are divided into two groups: control and erythrosine group. 7 Wistar albino rats were administered 5 ml erythrosine (2mg/ml) by gavage at 7-8-9-10-11 th days of their pregnancy. 10 rats in positive control group are given distilled water by gavage. At 20 th day of pregnancy, pregnant rats in both groups sacrificed by cervical dislocation and laparotomy applied. Each live fetus was promptly weighed and examined for congenital anomalies and the crown-rump lenght was measured. Routine fetal histologic studies and light microscopic examination of the sections stained with H&E was applied. Mast cells are examined in the fetal dermal sections stained with Toluidine Blue. In erythrosine group, there were no congenital defects, while the number of mast cells of fetal skins were increased and exocytosis was observed. This was statistically significant (U=12 p
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Renal Ultrastructural Alterations Following Administration of Diethylstilbestrol

Bilge ONARLIOĞLU

Global ischemia and turn preference: A comparative study of the effects of global ischemic insult in rats

Akçahan GEPDİREMEN, Mehmet Emin BÜYÜKOKUROĞLU, Cemal GÜNDOĞDU, Halis SÜLEYMAN, Sinan SÖNMEZ, Dilek SADELER

Effects of Gliclazide and Insulin Therapy on Thromboxane B 2 and 6-Keta-PGF 1a Levels in Type II Diabetic Patients

Ahmet Gökhan ÖZGEN

Global Ischemia and Turn Preference; A Comparative Study of the Effects of Global Ischemic Insult in Rats

Akçahan GEPDİREMEN

Cytochrome P-450 Reductase Activities in the Liver Microsomes of Diabetic Rats Induced With Some Chemical Solvents

Yavuz SİLİĞ, Öge ÇETİNKAYA

The Effect of Diphtheria Toxin on Nitric Oxide Induction From RAW264.7 Murine Macrophages

Cemalettin AYBAY, Başak KAYHAN, Turgut İMİR, Gülnur TARHAN

Effects of gliclazide and insulin therapy on thromboxane B2 and 6-keta-PGF1alpha levels in type II diabetic patients

Ahmet Gökhan ÖZGEN, Oya BAYINDIR, Füsun HAMULU, Candeğer YILMAZ, Metin ÇETİN, Dilek ÖZMEN

The Effect of Treatment Types on Plasma Levels of Lipoproteins, Apolipoproteins and LCAT in Type II Diabetes Mellitus

Eser VARDARELİ, Fahrettin AKYÜZ, Mine İNAL, Esat ERENOĞLU, Belgin EFE

Plasma fibronectin and urine glycosaminogiycane levels in rheumatic diseases

Nuriye METE, Mahmut METE, İ. Hakkı ÖZTÜRK, Leyla ÇOLPAN

Incidence of Listeria spp. from Raw Milk in Sivas

Gülhan VARDAR-ÜNLÜ, Mustafa Zahir BAKICI, Mehmet ÜNLÜ